The conference will offer valuable insights into lung cancer delivered by key representatives from the scientific, academic, and research community from all over the world. We are also delighted to welcome multiple state representatives, patient organisations, and pharma industry professionals.
Over 60 speakers and commentators will address the various challenges and approaches in:
- Advances in the implementation of lung cancer screening in Greece.
- Diagnostic steps and the role of artificial intelligence.
- Approaching early and advanced stages of lung cancer.
- The role of clinical trials in oncology.
- Personalised therapies.
- Holistic management of the disease.
The event will be moderated by journalist Elena Papadimitriou.
Simultaneous interpretation will be provided (Greek – English).